login
login

Europe Daily Bulletin No. 12856

18 December 2021
Contents Publication in full By article 14 / 32
EU RESPONSE TO COVID-19 / Health
EMA recommendations on three Covid-19 treatments and Johnson & Johnson’s vaccine booster
Brussels, 17/12/2021 (Agence Europe)

On Thursday 16 December, the European Medicines Agency (EMA) recommended the use of two new treatments for Covid-19: - Xevudy (sotrovimab), the monoclonal antibody developed by GSK (see EUROPE B12835A21); - Kineret (anakinra), an immunosuppressive drug previously authorised in the EU for the treatment of inflammatory conditions.

The EMA says that Xevudy is intended for the treatment of Covid-19 in adults and adolescents aged 12 years and over who are at increased risk of developing a severe...

Contents

EXTERNAL ACTION
SECTORAL POLICIES
EU RESPONSE TO COVID-19
SOCIAL AFFAIRS
EUROPEAN PARLIAMENT PLENARY
COURT OF JUSTICE OF THE EU
ECONOMY - FINANCE - BUSINESS
NEWS BRIEFS